References
- Carson CC. Francois Gigot de la Peyronie (16781747). Invest Urol. 1981;19:62–64.
- Nehra A, Alterowitz R, Culkin DJ, et al. American urological association education and research, inc. Peyronie’s disease: AUA Guideline. J Urol. 2015 Sep;194(3):745–753.
- Langston JP, Carson CC 3rd. Peyronie’s disease: review and recent advances. Maturitas. 2014 Aug;78(4):341–343.
- Sharma KL, Alom M, Trost L. The etiology of Peyronie’s disease: pathogenesis and genetic contributions. Sex Med Rev. 2020 Apr;8(2):314–323.
- Nelson CJ, Diblasio C, Kendirci M, et al. The chronology of depression and distress in men with Peyronie’s disease. J Sex Med. 2008;5:1985.
- Carson CC, Levine LA. Outcomes of surgical treatment of Peyronie’s disease. BJU Int. 2014 May;113(5):704–713.
- Mulhall JP, Creech SD, Boorjian SA, et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350–2353.
- Jordan GH, Carson CC, Lipshultz LI. Minimally invasive treatment of Peyronie’s disease: evidence-based progress. BJU Int. 2014 Jul;114(1):16–24.
- Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie’s disease. Nat Clin Pract Urol. 2005;2(6):291–297.
- Herati AS, Pastuszak AW. The genetic basis of Peyronie disease: a review. Sex Med Rev. 2016 Jan;4(1):85–94.
- Lyles KW, Gold DT, Newton RA, et al. Peyronie’s disease is associated with Paget’s disease of bone. J Bone Miner Res. 1997;12:929–934.
- Kirby EW, Verges D, Matthews J, et al. Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie’s disease or erectile dysfunction and does not correlate with Peyronie’s disease severity. J Sex Med. 2015 Mar;12(3):690–696.
- Montorsi F, Salonia A, Maga T, et al. Evidence-based assessment of long-term results in plaque incision and vein grafting for Peyronie’s disease. J Urol. 2000;163:1704–1708.
- Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie’s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010 Apr;7(4):215–221.
- Gelbard M, Goldstein I, Hellstrom WJ, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013 Jul;190(1):199–207.
- Carson CC 3rd, Sadeghi-Nejad H, Tursi JP, et al. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie’s disease (PD). BJU Int. 2015 Nov;116(5):815–822.
- Wymer K, Kohler T, Trost L. Comparative cost-effectiveness of surgery, collagenase clostridium histolyticum, and penile traction therapy in men with peyronie’s disease in an era of effective clinical treatment. J Sex Med. 2019 Sep;16(9):1421–1432.
- Capogrosso P, Frey A, Jensen CFS, et al. Low-intensity shock wave therapy in sexual medicine-clinical recommendations from the European society of sexual medicine (ESSM). J Sex Med. 2019 Oct;16(10):1490–1505.
- Abdel Raheem A, Johnson M, Abdel-Raheem T, et al. Collagenase clostridium histolyticum in the treatment of Peyronie’s disease-a review of the literature and a new modified protocol. Sex Med Rev. 2017;5(4):529–535.
- Cocci A, Russo GI, Salamanca JIM, et al. The end of an era: withdrawal of xiapex (Clostridium histolyticum Collagenase) from the European market. Eur Urol. 2020;77(5):660–661.
- Langston JP, Carson CC 3rd. Peyronie disease: plication or grafting. Urol Clin North Am. 2011 May;38(2):207–216.
- Flores S, Choi J, Alex B, et al. Erectile dysfunction after plaque incision and grafting: short-term assessment of incidence and predictors. J Sex Med. 2011 Jul;8(7):2031–2037.
- Habous M, Tealab A, Farag M, et al. Malleable penile implant is an effective therapeutic option in men with peyronie’s disease and erectile dysfunction. Sex Med. 2018 Mar;6(1):24–29.
- Lyons MD, Carson CC, Coward RM. Special considerations for placement of an inflatable penile prosthesis for the patient with Peyronie’s disease: techniques and patient preference. Med Devices (Auckl). 2015 Jul 27;8:331–340. .